Procedures designed to prevent objectionable microorganisms in drug substance not required to be sterile are not effective.
Inspection Record
Yuki Gosei Kogyo, Co., Ltd — FDA 483 Findings
Inspectors Tamil ArasuThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Your supplier qualifications are deficient.
There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch or any of its components to meet any of its specifications whether or not the batch has been already distributed.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
A record as of the US FDA document published on 2026-11-05. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.